Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily ...( AUSTIN Texas July 2...)

AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port(R) and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in the treatment of diabetes.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090727/DA51373)

The two companies are working together to design and develop the i-port Advance(TM), the first subcutaneous injection port for people taking multiple daily injections to include a disposable inserter, that will assist patients with the application process and eliminate the need for manual insertion. The i-port Advance(TM), similar in design to the i-port(R), will also provide improved features which may help to reduce insertion pain and enhance the user experience.

"We are excited about working with a global, industry leading company such as Unomedical which, like us, believes in the injection port therapy market opportunity. With the i-port Advance(TM), users will experience an application feature similar to the inserter technology used to apply most insulin pump infusion sets. Based on feedback received from people living with diabetes, diabetes educators, physicians and hospital nurses, we believe the i-port Advance(TM) may help alleviate the potential for error from an improper manual insertion while providing the key benefit of having a simple way to deliver injections without the need to puncture the skin for each dose of medication." John Burns, President, Patton Medical Devices

As part of the agreement, Patton Medical Devices has exclusive rights to market and distribute the i-port Advanc
'/>"/>